Related Experiment Videos
[Heart transplantation in children]
1Dĕtské kardiocentrum 2. LF UK a FNM, Praha. tomas.tlaskal@lfmotol.cuni.cz
Casopis Lekaru Ceskych
|July 5, 2003
Summary
Pediatric heart transplantation offers a life-saving option for intractable heart diseases. Improving immunosuppression and addressing donor shortages are key to enhancing long-term survival and quality of life.
Area of Science:
- Cardiology
- Pediatric Surgery
- Immunology
Context:
- Heart transplantation is the definitive treatment for pediatric end-stage heart disease.
- Common indications include cardiomyopathy, congenital heart defects, and post-surgical heart failure.
- Hypoplastic left heart syndrome is a leading reason for transplantation in neonates and infants.
Purpose:
- To review current pediatric heart transplantation practices, outcomes, and challenges.
- To highlight common complications and factors influencing long-term survival.
- To identify areas for future research and improvement in pediatric heart transplantation.
Summary:
- Pediatric heart transplantation survival rates are 80% at one year and 50% at ten years, with better outcomes in neonates.
- Graft failure, rejection, and infection are primary causes of mortality.
- Post-transplant graft vasculopathy is a critical late complication requiring retransplantation.
- Steroid-free immunosuppression is often used in infants, with withdrawal at 6-12 months post-transplant.
Impact:
- Enhanced transplantation programs can improve survival rates and quality of life.
- Further research is needed for safer, more effective immunosuppressive therapies and to address donor scarcity.
- Investigating mechanical support and xenotransplantation holds potential for future advancements.